Pfizer And Sanofi China GMs Disagree On Commercial Models – PharmAsia Summit Shanghai
This article was originally published in PharmAsia News
Executive Summary
Pfizer Inc.’s Wu Xiaobing and Sanofi China’s Fabrice Baschiera discuss how their companies are creating value for patients and payers in China during a keynote panel during the PharmAsia Summit in Shanghai.